Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma (Q39491260)

12 September 2017

title

Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma (English)

1 reference

12 September 2017

1 reference

Kosuke Tsutsumi

1

1 reference

12 September 2017

Norihiro Sato

2

1 reference

12 September 2017

Reiko Tanabe

3

1 reference

12 September 2017

Kazuhiro Mizumoto

4

1 reference

12 September 2017

Katsuya Morimatsu

5

1 reference

12 September 2017

Tadashi Kayashima

6

1 reference

12 September 2017

Hayato Fujita

7

1 reference

12 September 2017

Kenoki Ohuchida

8

1 reference

12 September 2017

Takao Ohtsuka

9

1 reference

12 September 2017

Shunichi Takahata

10

1 reference

12 September 2017

Masafumi Nakamura

11

1 reference

12 September 2017

Masao Tanaka

12

1 reference

12 September 2017

publication date

12 August 2011

1 reference

Annals of Surgical Oncology

12 September 2017

published in

1 reference

12 September 2017

volume

19 Suppl 3

1 reference

12 September 2017

page(s)

S491-9

1 reference

Prognosis of human pancreatic adenocarcinoma: review of clinical and histopathological variables and possible uses of new molecular methods

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

One thousand consecutive pancreaticoduodenectomies

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Expressions of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Molecular prognostic markers in pancreatic cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

S100A4 mRNA is a diagnostic and prognostic marker in pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

The claudin gene family: expression in normal and neoplastic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Identification, culture, and characterization of pancreatic stellate cells in rats and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Towards quantitative mRNA analysis in paraffin-embedded tissues using real-time reverse transcriptase-polymerase chain reaction: a methodological study on lymph nodes from melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

The expression of claudin-1, claudin-2, claudin-3, and claudin-4 in gastric cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Claudins regulate the intestinal barrier in response to immune mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Antagonistic effect of NK4 on HGF/SF induced changes in the transendothelial resistance (TER) and paracellular permeability of human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Na,K-ATPase beta-subunit is required for epithelial polarization, suppression of invasion, and cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Expression pattern and prognostic significance of claudins 1, 4, and 7 in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Expression of tight-junction-associated proteins in human gastric cancer: downregulation of claudin-4 correlates with tumor aggressiveness and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Therapeutic antitumor efficacy of monoclonal antibody against Claudin-4 for pancreatic and ovarian cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Claudin-4-targeting of diphtheria toxin fragment A using a C-terminal fragment of Clostridium perfringens enterotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

p16INK4a is a Prognostic Marker in Resected Ductal Pancreatic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1970-2

10.1245/S10434-011-1970-2

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

12 September 2017

1006550798

0 references

1 reference